A potent and highly selective sulfotransferase inhibitor

Journal of the American Chemical Society

Volumn 124, Issue 49, 2002, Pages 14524-14525

  Chapman, Eli ^a   Ding, Sheng ^a   Schultz, Peter G ^a,b   Wong, Chi Huey ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SULFOTRANSFERASE; SULFOTRANSFERASE INHIBITOR; SULFOTRANSFERASE IV; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; INHIBITION KINETICS;

ADENOSINE DIPHOSPHATE; ANIMALS; BINDING, COMPETITIVE; COMBINATORIAL CHEMISTRY TECHNIQUES; ENZYME INHIBITORS; KINETICS; PURINES; PYRIMIDINES; RATS; SULFOTRANSFERASES;

EID: 0037065313     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja021086u     Document Type: Article

References (23)

1. (a) Armstrong, J. I.; Bertozzi, C. R. Curr. Opin. Drug Discuss. Devel. 2000, 3, 502.
2. (b) Falany, C. N. FASEB 1997, 11, 1.
3. (c) Weinshilboum, R. M.; Ottemess, D. M.; Ibrahim, A. A.; Wood, T. C.; Her, C.; Raftogianis, R. B. FASEB 1997, 11, 3.
4. (d) Runge-Morris, M. A. FASEB 1997, 11, 109.
5. (e) Falany, C. N. FASEB 1997, 11, 206.
6. (f) Glatt, H. FASEB 1997, 11, 314.
7. (g) Klaassen, C. D.; Boles, J. W. FASEB 1997, 11, 404.
8. (h) Varin, L.; Marsolais, F.; Richard, M.; Rouleau, M. FASEB 1997, 11, 517.
9. (i) Habuchi, O. Biochim. Biophys. Acta 2000, 1474, 115.
10. (a) Shukla, D.; Liu, J.; Blaiklock, P.; Shworak, N. W.; Bai, X.; Esko, J. D.; Cohen, G. H.; Eisenberg, R. J.; Rosenberg, R. D.; Spear, P. G. Cell 1999, 99, 13.
11. (b) Farzan, M.; Mirzabekov, T.; Kolchinsky, P.; Wyatt, R.; Cayabyab, M.; Gerard, N. P.; Gerard, C.; Sodroski, J.; Choe, H. Cell 1999,. 96, 667.
12. (c) Cornier, E. G.; Persuh, M.; Thompson, D. A. D.; Lin, S. W.; Sakmar, T. P.; Olson, W. C.; Dragic, T. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 5762.
13. (d) Kansas, G. S. Blood 1996, 88, 3259.
14. (a) Kehoe, J. W.; Maly, D. J.; Verdugo, D. E.; Armstrong, J. I.; Cook, B. N.; Ouyang, Y.-B.; Moore, K. L.; Ellman, J. A.; Bertozzi, C. R. Bioorg. Med. Chem. Lett. 2002, 12, 329.
15. (b) Verdugo, D. E.; Cancilla, M. T.; Ge, X.; Gray, N. S.; Chang, Y.; Schultz, P. G.; Negishi, M.; Leary, J. A.; Bertozzi, C. R. J. Med. Chem. 2001, 44, 2683.
16. (c) Armstrong, J. I.; Ge, X.; Verdugo, D. E.; Winans, K. A.; Leary, J. A.; Bertozzi, C. R. Org. Lett. 2001, 3, 2657.
17. Burkart, M. D.; Izumi, M.; Chapman, E.; Lin, C.-H.; Wong, C.-H. J. Org. Chem. 2000, 65, 5565.
18. Duffel, M. W.; Marshall, A. D.; McPhie, P.; Sharma, V.; Jakoby, W. B. Drug Metab. Rev. 2001, 33, 369.
19. Ding, S.; Gray, N. S.; Wu, X.; Ding, Q.; Schultz, P. G. J. Am. Chem. Soc. 2002, 124,1594.
20. -1.
21. The compounds that were resynthesized were done using the procedure reported in ref 6, except all reactions were carried out in the solution phase.
22. Segel, I. H. Enzyme Kinetics; John Wiley & Sons: New York, 1975; pp 100-124.
23. Chapamn, E.; Bryan, M. C.; Wong, C.-H. Proc. Natl. Acad. Sci. U.S.A. 2000. In press.